GGrantIndex
← Leaderboards

Ling Li

University Of Alabama At Birmingham

$7,828,511
Attributed
$11,661,805
Total exposure
9
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY200525
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,661,805 · 9

By mechanism

RF1$5,932,955 · 3
R01$4,140,294 · 3
P01$844,991 · 1
R21$743,565 · 2

Top collaborators

Most similar at University Of Alabama At Birmingham

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposCognitive FunctionBrainMouse ModelImpaired CognitionCerebrumS DiseaseMolecularDementiaLeadBehavioralAmyloid DepositionPathway InteractionsMediatingNeuronsAffectSynapsesPlasmaTransgenic OrganismsAmericanPrevalenceBasePreventElderly

Grant awards (20)

Acute and Long-Term Impact of SARS-CoV-2 Infection and its Interaction with APOE on Cognitive Function and Neuropathology in Aging and Alzheimer's Disease$699,107
R01 · FY2025 · AG · contact PI
Impact of Mitochondrial Lipidomic Dynamics and its Interaction with APOE Isoforms on Brain Aging and Alzheimers Disease$638,436
R01 · FY2025 · AG · contact PI
Impact of Mitochondrial Lipidomic Dynamics and its Interaction with APOE Isoforms on Brain Aging and Alzheimers Disease$658,484
R01 · FY2024 · AG · contact PI
Impact of Mitochondrial Lipidomic Dynamics and its Interaction with APOE Isoforms on Brain Aging and Alzheimers Disease$664,641
R01 · FY2023 · AG · contact PI
Acute and Long-Term Impact of SARS-CoV-2 Infection and its Interaction with APOE on Cognitive Function and Neuropathology in Aging and Alzheimer's Disease$2,172,765
RF1 · FY2022 · AG · contact PI
HDL Mimetic Peptide-Mediated Enhancement of Neurovascular Function to Mitigate Cerebral Amyloid Angiopathy and Alzheimer's Disease$1,884,326
RF1 · FY2018 · AG · contact PI
Testing a Unique HDL Mimetic Peptide to Reverse ApoE4 Lipidation Deficiency and Alzheimer's Neuropathology$229,532
R21 · FY2018 · AG · contact PI
Dysregulation of Protein Prenylation in the Pathogenesis of Alzheimer's Disease$1,875,864
RF1 · FY2017 · AG · contact PI
Testing a Unique HDL Mimetic Peptide to Reverse ApoE4 Lipidation Deficiency and Alzheimer's Neuropathology$189,846
R21 · FY2017 · AG · contact PI
Protective Mechanisms of Statins in Alzheimer's Disease$293,758
R01 · FY2012 · AG · contact PI
Protective Mechanisms of Statins in Alzheimer's Disease$297,090
R01 · FY2011 · AG · contact PI
Protective Mechanisms of Statins in Alzheimer's Disease$240,446
R01 · FY2010 · AG · contact PI
Protective Mechanisms of Statins in Alzheimer's Disease$53,832
R01 · FY2010 · AG · contact PI
Protective Mechanisms of Statins in Alzheimer's Disease$297,250
R01 · FY2009 · AG · contact PI
Protective Mechanisms of Statins in Alzheimer's Disease$297,250
R01 · FY2008 · AG · contact PI
Core--Molecular biology$291,326
P01 · FY2006 · HL · contact PI
Effects of Statins on AD beyond Cholesterol and Amyloid$145,632
R21 · FY2006 · AG · contact PI
Core--Molecular biology$283,687
P01 · FY2005 · HL
Effects of Statins on AD beyond Cholesterol and Amyloid$178,555
R21 · FY2005 · AG
Core--Molecular biology$269,978
P01 · FY2002 · HL